10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 331 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,636,095 | -26.6% | 84,118 | +41.7% | 0.01% | 0.0% |
Q1 2024 | $2,227,668 | -32.9% | 59,357 | 0.0% | 0.01% | -36.4% |
Q4 2023 | $3,321,618 | +59.8% | 59,357 | +17.8% | 0.01% | +57.1% |
Q3 2023 | $2,078,051 | -31.2% | 50,377 | -6.9% | 0.01% | -30.0% |
Q2 2023 | $3,020,274 | +9.6% | 54,088 | +9.5% | 0.01% | 0.0% |
Q1 2023 | $2,756,919 | +19.7% | 49,416 | -21.8% | 0.01% | +11.1% |
Q4 2022 | $2,303,773 | +27.9% | 63,221 | 0.0% | 0.01% | +28.6% |
Q3 2022 | $1,801,000 | -29.3% | 63,221 | +12.2% | 0.01% | -30.0% |
Q2 2022 | $2,549,000 | -32.7% | 56,330 | +13.1% | 0.01% | -16.7% |
Q1 2022 | $3,790,000 | -45.4% | 49,823 | +6.9% | 0.01% | -40.0% |
Q4 2021 | $6,942,000 | +5.5% | 46,601 | +3.1% | 0.02% | 0.0% |
Q3 2021 | $6,582,000 | -25.2% | 45,210 | +0.6% | 0.02% | -31.0% |
Q2 2021 | $8,801,000 | +22.6% | 44,942 | +13.3% | 0.03% | +16.0% |
Q1 2021 | $7,180,000 | +166.9% | 39,666 | +108.8% | 0.02% | +150.0% |
Q4 2020 | $2,690,000 | – | 19,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |